An Opportunity Missed: Managing an Aggressive Adrenal Cortical Carcinoma

    Nasrin Saleh Jouneghani, Kathreen Al-Ramo, Wendy White
    Image of study
    TLDR The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.
    The document discusses a case of a 42-year-old woman with an aggressive form of Adrenal Cortical Carcinoma (ACC), a rare endocrine tumor. The tumor grew from 4 cm to 17 cm within 4 months, metastasizing to the lung, liver, and left kidney before resection. The patient initially presented with abdominal pain and hypokalemia, and an incidental left adrenal mass was discovered. However, she was lost to follow-up for 3 months. Upon return, the tumor had significantly increased in size and metastasized. Post-operative symptoms included new-onset hirsutism, male-pattern hair loss, proximal muscle weakness, and significant weight loss. The patient declined further therapy for her ACC and died 2 weeks later. The case emphasizes the need for timely and complete biochemical evaluation of adrenal incidentalomas, especially when radiologic features such as size more than 4 cm and heterogeneous appearance are present.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 64 results

      community Anyone know how to get second gen NSAA in the uk.

      in Transgender  1 upvotes 2 weeks ago
      A transwoman is struggling with hair loss despite using hormones, dutasteride, and Abiraterone, and is considering making her own treatments due to difficulty accessing them. She has also tried Eucapil and regularly uses Nizoral shampoo.

      community Now i want to see if this DHT survives

      in Treatment  31 upvotes 3 months ago
      The conversation discusses using minoxidil, finasteride, spironolactone, and RU58841 for hair loss treatment. Users share experiences with these treatments, noting side effects and varying effectiveness.

      community EMA is re-examining Winlevi (clascoterone at lower concentration)

      in Treatment  9 upvotes 3 months ago
      Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

      community My personal thoughts on DHT. belive it or not

      in Research/Science 10 months ago
      The conversation discusses a personal theory on the role of DHT in stress and reproduction, suggesting it converts testosterone for reproductive traits. The discussion includes skepticism and mentions individual differences in physiology and neurochemistry.

      community Mechanism of action of alfatradiol (17 alpha estradiol)

      in Research/Science  6 upvotes 1 year ago
      The conversation discusses the mechanism of action of alfatradiol (17 alpha estradiol) in treating hair loss. It explores theories that it either inhibits 5 alpha reductase to prevent T->DHT conversion or aromatizes scalp T into 17-alpha-estradiol to save hair.

    Similar Research

    5 / 1000+ results